Synedica Retatrutide Research Behind New Treatments
Triple receptor agonists represent a major leap forward in peptide science, typically targeting GLP-1, GIP, and glucagon receptors simultaneously. By engaging these distinct metabolic pathways at once, these advanced compounds generate synergistic biological effects that…